Aluminium complexes bearing sterically bulky benzotriazole-phenoxide ligands are synthesized and characterized structurally. The reaction of 2-(2H-benzotriazol-2-yl)-4,6-bis(1-methyl-1-phenylethyl)phenol ((CMe2Ph)BTP-H) or 2-(2H-benzotriazol-2-yl)-4,6-di-tert-butylphenol ((t-Bu)BTP-H) with AlMe(3) (1.2 molar equiv.) in toluene yields [((CMe2Ph)BTP)AlMe(2)] (1) or [((t-Bu)BTP)AlMe(2)] (2) as a four-coordinated monomeric aluminium complex. Compound 1 reacts further with (CMe2Ph)BTP-H in a stoichiometric proportion, affording penta-coordinated monomeric aluminium methyl complex [((CMe2Ph)BTP)(2)AlMe] (3). Complex 3 is also obtained directly upon treatment of AlMe(3) with (CMe2Ph)BTP-H (two molar equiv.) in refluxing toluene in high yield. In the presence of H(2)O (half a molar equiv.), hydrolysis of 3 in a mixed solvent of THF and toluene at ambient temperature affords [{((CMe2Ph)BTP)(2)Al}(2)(μ-O)] (4), in which the oxo ligand acts as a chelating group linearly bridging two aluminium centers. Air-stable alumoxane 4 is an efficient catalyst for the ring-opening polymerization of L-lactide (L-LA) in the presence of 9-anthracenemethanol (9-AnOH). Complex 4 catalyzes the polymerization of L-LA in a controlled manner, yielding PLLAs with the expected molecular weights and narrow polydispersity indices (PDIs).
No takes yet. Share an insight, caveat, or question.
Li et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: